Sublingual sildenafil in the treatment of erectile dysfunction: Faster onset of action with less dose

@article{Deveci2004SublingualSI,
  title={Sublingual sildenafil in the treatment of erectile dysfunction: Faster onset of action with less dose},
  author={Serkan Deveci and Levent Peşkircioğlu and Cem Ayg{\"u}n and Mehmet Ilteris Tekin and Ayhan Dirim and Hakan {\"O}zkardeş},
  journal={International Journal of Urology},
  year={2004},
  volume={11}
}
Background: The aim of the present study was to show the efficacy and safety of sublingual sildenafil and to determine whether lower doses cause the same effect with a faster onset of action in this mode of application. 
Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction
TLDR
This review focuses on biochemical and pharmacological features of sildenafil, the active component in Viagra, interaction with phosphodiesterase 5, pharmacokinetic parameters, action in smooth muscle, side effects, safety profile and prospects for other uses.
Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?
  • S. Doggrell
  • Medicine
    International Journal of Impotence Research
  • 2007
TLDR
Sildenafil, vardenafil and tadalafil have all been shown to be similarly effective in the treatment of men with ED of vary etiologies, to have similar adverse effects profiles, and to improve quality-of-life by similar amounts.
The first‐generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue
TLDR
The use of phosphodiesterase 5 inhibitors (PDE5is) has revolutionized the treatment of ED, but a high percentage of ED patients discontinue PDE5i treatment.
Reconstructive surgery Indications of periureteral injections in the child and adolescent with reflux Related review: Role of periureteral injections in children with vesicoureteral reflux
  • Pp
  • Medicine
  • 2005
TLDR
Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux with improved results with submucosal implantation within the intramural ureter.
Produit de traitement du dysfonctionnement erectile chez l'homme
L'invention concerne l'utilisation de trigluconate sildenafile comme produit de traitement du dysfonctionnement erectile chez l'homme.
A meta-regression evaluating the effectiveness and prognostic factors of oral phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction
TLDR
PDE5-Is are more effective in Caucasians than Asians, and in patients with more severe ED, according to a random effects meta-regression model.
Formulation and Characterization of Rizatriptan Benzoate Sublingual Tablet with Various Permeation Enhancers
TLDR
The present work of formulating a sublingual tablet containing Rizatriptan benzoate was successful in terms of reducing manufacturing difficulties, cost and providing better patient compliance with effective medication.
...
1
2
3
...

References

SHOWING 1-10 OF 13 REFERENCES
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.
TLDR
Oral sildenafil is an effective, well-tolerated treatment for men with erectile dysfunction and is associated with improved erectile function in the dose-response study.
ORAL SILDENAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION
TLDR
Oral sildenafil is an effective, welltolerated treatment for men with erectile dysfunction and is associated with improved erectile function in the dose–response study.
Onset and duration of action of sildenafil for the treatment of erectile dysfunction.
TLDR
Sildenafil is an effective oral treatment for ED that produces a penetrative erection as early as 12 min and for most patients, within 30 min after dosing, and a duration of action lasting at least 4 h.
Clinical safety of oral sildenafil citrate (VIAGRATM) in the treatment of erectile dysfunction
TLDR
The overall clinical safety of oral sildenafil, a potent inhibitor of phosphodiesterase type 5, in the treatment of erectile dysfunction was evaluated in more than 3700 patients, with a total of 1631 years of exposure worldwide.
Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment.
TLDR
The best predictors for response to sildenafil citrate therapy are baseline sexual function and etiology of erectile dysfunction, however, no patient characteristic was identified that would predict absolute failure for sildanafilcitrate therapy.
The Clinical Safety of Viagra
TLDR
Erectile dysfunction in men is amenable to correction with Viagra in a majority of patients and the use of Viagra for erectile dysfunction, in the absence of contraindications, is extremely safe provided the drug is taken under proper conditions.
Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee.
TLDR
It is possible that a precipitous reduction in blood pressure with nitrate use may occur over the initial 24 hours after a dose of Viagra, and for patients who experience an acute cardiac ischemic event and who have taken Viagra within the past 24 hours, administration of nitrates should be avoided.
Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality.
TLDR
Sildenafil had a mean absolute bioavailability of 41%, and food caused small reductions in the rate and extent of systemic exposure; these reductions are unlikely to be of clinical significance.
Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction
TLDR
For 1152 men (1036 with ED, 116 controls) analyzed, a receiver operating characteristic curve indicated that the IIEF-5 is an excellent diagnostic test.
Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition
TLDR
The clinical importance of any drug interaction depends on factors that are drug-, patient- and administration-related and is likely to be dependent on interindividual differences in CYP3A4 tissue content, pre-existing medical conditions and, possibly, age.
...
1
2
...